Synmosa Biopharma was founded in 1980. In the early days, the company started as an importer for pharmaceutical products; with its developing strategy, Synmosa nowadays has its business coverage in the pharmaceutical research and development, manufacturing, distribution, and sales and marketing activities deeply involved in cardiovascular, respiratory, and hormone therapy area. Our sales channels include all hospitals, general practices, and drug stores in Taiwan, Hong Kong, and China. Moreover, our branded products also have been exported and successfully marketed in the Southeast Asia region. Synmosa has conducted business with its core values: "Integrity", "Trust", "Accountability", and "Innovation" for the past thirty years. Synmosa has become one of the leading companies in the pharmaceutical industry with its innovative technology in drug formulation and strong marketing power.
health care & pharmaceutical products- timeless & flat gold serum, timeless micro brightness creams, creamy cleansing milk, timeless revitalizing gel, innovative pharmaceutical and health care products, prescription drugs, anti-inflammatory analgesics, cardiovascular Products, hormone replacement treatment ( HRT), metabolic therapeutic products, muscle relaxant, neurological/ psychiatric medicines, respiratory medicines, urological products, OTC ( over-the-counter) medicine, dermatologic products, gastro-intestinal products, cold Symptom relief/ expectorants, vitamins ( A, C, E, B1, B2, B3, B6, B12, etc), nutrition/ food supplement, cosmetic products, brightness cream, skin whitening serum, skin revitalizing gel cream, moisture & cleaning lotions.
|Business Nature :||Manufacturer, Importer, Exporter, Trader, Agent, ODM, OEM|
|Year Established :||1980|
|Company Capital :||USD 100,000,001 ~|
|Annual Revenue :||USD 100,000,001 ~|
|President :||Mr. Peter Lin|
|No. of Total Staff :||251 ~ 500|
|Current Export Markets :||Worldwide|
|Brand Names :||Synmosa|
|Trade Term :||CIF|
|Shipment :||Sea, Air|
|Delivery Time :||120 days|
|Payment Terms :||L/C at sight, T/T|